Alkermes Shareholders Re-Elect All Seven Company Director Nominees

 No Sarissa Nominees Elected by Shareholders

Alkermes plc (Nasdaq: ALKS) (the Company) today announced that, at the Company's 2023 Annual General Meeting of Shareholders (the Annual Meeting), shareholders voted to re-elect all seven of Alkermes' director nominees – Emily Peterson Alva, Shane M. Cooke, Richard B. Gaynor, M.D., Cato T. Laurencin, M.D., Ph.D., Brian P. McKeon, Richard F. Pops and Christopher I. Wright, M.D., Ph.D. Sarissa Capital Management LP nominees Alexander Denner, Ph.D., Patrice Bonfiglio and Sarah Schlesinger, M.D. failed to achieve the necessary votes for election. Additionally, all other Company proposals were approved by shareholders.

Nancy J. Wysenski, Lead Independent Director of Alkermes' Board of Directors, said, "We are pleased that all seven Company nominees were re-elected to the Board and appreciate the active engagement with our shareholders as well as their feedback and support. We believe this outcome is a reflection of our strong performance and robust corporate governance practices. Looking ahead, we remain focused on executing on our strategic priorities for the benefit of all shareholders, including our commitment to operational efficiency, disciplined capital allocation and profitability. We recognize that our work is far from done and look forward to continuing our active engagement with shareholders as we seek to drive significant value creation."

https://finance.yahoo.com/news/alkermes-shareholders-elect-seven-company-145000083.html